Our findings demonstrated that lymphocyte subsets features, especially CD16+CD56+%, CD4+/CD8+ ratio, CD19+, and CD3+CD4+ independently predicted the differentiation of COVID-19 and CAP. This evidence concerns the gene CD4 and COVID-19.